Información del artículo
El Texto completo está disponible en PDF
Biblografía
[1.]
G. Boden.
Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.
Diabetes, 46 (1997), pp. 1-10
[2.]
R.S. Ahima, J.S. Flier.
Adipose tissue as an endocrine organ.
Trends Endocrinol Metab, 11 (2000), pp. 327-332
[3.]
P. Trayhurn, J.H. Beattie.
Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.
Proc Nutr Soc, 60 (2001), pp. 329-339
[4.]
L. Shimomura, R.E. Hammer, S. Ikemoto, M.S. Brown, J.L. Goldstein.
Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.
Nature, 401 (1999), pp. 73-76
[5.]
G.S. Hotamisligil.
The role of á-TNF and TNF receptors in obesity and insulin resistance.
J Int Med, 245 (1999), pp. 621-625
[6.]
J.P. Bastard, C. Jardel, E. Bruckert, P. Blondy, J. Capeau, M. Laville, et al.
Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese woman after weight loss.
J Clin Endocrinol Metab, 85 (2000), pp. 3338-3342
[7.]
H. Kondo, I. Shimomura, Y. Matsukawa, M. Kumada, M. Takahashi, M. Matsuda, et al.
Association of adiponectin mutation with type 2 diabetes. A candidate gene for the insulin resistance syndrome.
Diabetes, 51 (2002), pp. 2325-2328
[8.]
C.M. Steppan, M.A. Lazar.
Resistin and obesity-associated insulin resistance.
Trends Endocrinol Metab, 13 (2002), pp. 18-23
[9.]
C.M. Steppan, S. Bailey, S. Bhat, E.J. Brown, R.R. Banerjee, C.M. Wright, et al.
The hormone resistin links obesity to diabetes.
Nature, 409 (2001), pp. 307-312
[10.]
I.N. Holcomb, R.C. Kabakoff, B. Chan, T.W. Baker, A. Gumey, W. Henzel, et al.
FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family.
EMBO J, 19 (2000), pp. 4046-4055
[11.]
C.M. Steppan, E.J. Brown, C.M. Wright, S. Bhat, R.R. Banerjee, C.Y. Dai, et al.
A family of tissue-specific resistin-like molecules.
Proc Natl Acad Sci USA, 98 (2001), pp. 502-506
[12.]
J.M. Way, C.Z. Gorgun, Q. Tong, K.T. Uysal, K.K. Brown, W.W. Harrington, et al.
Adipose tissue resistin is severely suppressed in obesity and stimulated by peroxisome proliferatoractivated receptor-γ agonists.
J Biol Chem, 276 (2001), pp. 25651-25653
[13.]
C.L. McTerman, P.G. McTerman, P.L. Levick, A.H. Barnett, S. Kumar.
Resistin, central obesity and type 2 diabetes.
Lancet, 359 (2002), pp. 46-47
[14.]
P.G. McTerman, C.L. McTerman, R. Chetty, K. Jenner, F.M. Fisher, M.N. Lauer, et al.
Increased resistin gene and protein expression in human abdominal adipose tissue.
J Clin Endocrinol Metab, 87 (2002), pp. 2407-2410
[15.]
I. Nagaev, U. Smith.
Insulin resistance and type 2 are not related to resistin expression in human fat cells or skeletal muscle.
Biochem Biophys Res Commun, 285 (2001), pp. 561-564
[16.]
D.B. Savage, C.P. Sewter, E.S. Klenk, D.G. Segal, A. Vidal-Puig, R.V. Considine, et al.
Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator activated receptor-γ action in humans.
Diabetes, 50 (2001), pp. 2199-2202
[17.]
J. Jurgen, S. Engell, K. Gorzelnniak, F. Luft, A.M. Sharma.
Resistin gene expresion in human adipocytes is not related to insulin resistance.
Obes Res, 10 (2002), pp. 1-5
[18.]
I. Barroso, M. Gurnell, V.E.F. Crowley, M. Agostini, J.W. Shcwabe, M.A. Soos, et al.
Dominant negative mutations in human PPAR-γ associated with severe insulin resistance, diabetes mellitus and hypertension.
Nature, 402 (1999), pp. 880-883
[19.]
F. Sentinelli, S. Romeo, M. Arca, E. Filippi, F. Leonetti, M. Banchieri, et al.
Human resistin gene, obesity and type 2 diabetes. Mutation analysis and population study.
Diabetes, 51 (2002), pp. 860-862
[20.]
H. Osawa, H. Onuna, A. Murakami, M. Ochi, T. Nishimiya, K. Kato, et al.
Systematic search for single nucleotide polymorphisms in the resistin gene. The absence of evidence for the association of three identified single nucleotide polymorphisms with japanese type 2 diabetes.
Diabetes, 51 (2002), pp. 863-866
[21.]
J.C. Engert, M.C. Volh, S.M. Williams, P. Lepage, J.C. Loredo-Osti, J. Faith, et al.
5'flanking variants of resistin are associated with obesity.
Diabetes, 1 (2002), pp. 1629-1634
[22.]
H. Wang, W.S. Chu, C. Hemphill, S.C. Elbein.
Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 in caucasians.
J Clin Endocrinol Metab, 87 (2002), pp. 2520-2524
[23.]
H.B. Hartman, X. Hu, K.X. Tyler, C.K. Dalal, M.A. Lazar.
Mechanisms regulating adipocyte expression of resistin.
J Biol Chem, 277 (2002), pp. 19754-19761
[24.]
A.R. Schuldiner, R. Yang, D.W. Gong.
Resistin, obesity, and insulin resistance .the emerging role of the adipocyte as an endocrine organ.
N Engl J Med, 345 (2001), pp. 1345-1346
[25.]
M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, R. Paschke.
Tumor necrosis factor is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes.
Biochem Biophys Res Commun, 288 (2001), pp. 1027-1031
[26.]
P. Peraldi, M. Xti, B.M. Spiegelman.
Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.
J Clin Invest, 100 (1997), pp. 1863-1869
[27.]
A. Vidal-Puig, S. O'Rahilly.
Resistin: a new link between obesity and insulin resistance?.
Clin Endocrinol, 55 (2001), pp. 437-438
Copyright © 2003. Sociedad Española de Endocrinología y Nutrición